About Paxman AB 
Paxman AB
Pharmaceuticals & Biotechnology
Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.
Company Coordinates 
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
75 Million
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
Pharmaceuticals & Biotechnology
SEK 1,503 Million (Small Cap)
180.00
NA
0.00%
-0.31
1.97%
3.53






